The FDA approves Kyprolis to treat patients with multiple myeloma who have received at least two...

The FDA approves Kyprolis to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade and an immunomodulatory therapy. Shares of Onyx (ONXX) remain halted.